Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer

Withdrawn before enrolling

Conditions studied: Breast Carcinoma Metastatic to the Bone, Stage IV Breast Cancer

In brief

This research trial studies the role of a substance called hyaluronic acid in causing the growth of cancer stem cells in the bones of patients with breast cancer. Cancer stem cells are a type of cancer cells that may cause the cancer to spread to other parts of the body. Studying samples of blood and bone marrow from patients and animal models in the laboratory may help doctors learn more about whether hyaluronic acid affects the growth of cancer in the bones.

Key facts

Study ID

NCT02331212

Run by

Wake Forest University Health Sciences

People needed

0

Starts

2015-03-01

Expected to finish

2017-06-01

Last updated by the study team

2018-07-02

Who can join

Age: 20 and older, up to 60. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have newly diagnosed, histologically confirmed primary and/or metastatic breast cancer
• Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document

You may not qualify if…

• Patients who have had chemotherapy or radiotherapy

Where it is running

• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.